"Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19." by Paolo Antonio Ascierto

Selected Works of Walter J. Urba, MD, PhD

Article

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

J Immunother Cancer

Paolo Antonio Ascierto
Bernard A Fox, Chiles Research Institute Providence Portland Medical Center
Walter Urba, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, 97213, USA.
Ana Carrizosa Anderson
Michael B Atkins
Ernest C Borden
Julie Brahmer
Lisa H Butterfield
Alessandra Cesano
Daniel Chen
Tanja de Gruijl
Robert O Dillman
Charles G Drake
Leisha A Emens
Thomas F Gajewski
James L Gulley
F Stephen Hodi
Patrick Hwu
David Kaufman
Howard Kaufman
Michael Lotze
Douglas G McNeel
Kim Margolin
Francesco Marincola
Michael J Mastrangelo
Marcela V Maus
David R Parkinson
Pedro J Romero
Paul M Sondel
Stefani Spranger
Mario Sznol
George J Weiner
Jon M Wiggington
Jeffrey S Weber

Link

Document Type

Article

Publication Date

4-1-2020

Keywords

Betacoronavirus,
Coronavirus Infections,
Drug Approval,
Humans,
Immunologic Factors,
Immunotherapy,
Inflammation,
Interleukin-6,
Neoplasms,
Pandemics,
Pneumonia, Viral,
Receptors, Interleukin-6,
2019-nCoV

Disciplines

Infectious Disease and
Oncology

Clinical Institute

Cancer

Department

Oncology

Department

Infectious Diseases

Citation Information

Paolo Antonio Ascierto, Bernard A Fox, Walter Urba, Ana Carrizosa Anderson, et al.. "Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19." J Immunother Cancer (2020)
Available at: http://works.bepress.com/walter-urba/297/